This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Oct 14;356(9238):1351.

doi: 10.1016/S0140-6736(00)02830-0.

Behçet's disease and interferon: flaws in research integrity of randomised trial

B Eldem

PMID: 11073040
DOI: 10.1016/S0140-6736(00)02830-0

Comment

Behçet's disease and interferon: flaws in research integrity of randomised trial

B Eldem. Lancet. 2000.

. 2000 Oct 14;356(9238):1351.

doi: 10.1016/S0140-6736(00)02830-0.

Author

B Eldem

PMID: 11073040
DOI: 10.1016/S0140-6736(00)02830-0

No abstract available

PubMed Disclaimer

Comment on

Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behçet's disease: a randomised trial.
Demiroglu H, Ozcebe OI, Barista I, Dündar S, Eldem B. Demiroglu H, et al. Lancet. 2000 Feb 19;355(9204):605-9. doi: 10.1016/S0140-6736(99)05131-4. Lancet. 2000. Retraction in: Lancet. 2000 Oct 14;356(9238):1292. doi: 10.1016/S0140-6736(00)02811-7. PMID: 10696980 Retracted. Clinical Trial.

Similar articles

Behçet's disease and interferon: flaws in research integrity of randomised trial.
Dündar S, Ozcebe OI. Dündar S, et al. Lancet. 2000 Oct 14;356(9238):1351. doi: 10.1016/S0140-6736(05)74255-0. Lancet. 2000. PMID: 11073041 No abstract available.
Behçet's disease and interferon: flaws in research integrity of randomised trial.
Sayek I. Sayek I. Lancet. 2000 Oct 14;356(9238):1351. doi: 10.1016/S0140-6736(05)74256-2. Lancet. 2000. PMID: 11073042 No abstract available.
Response to allegations and some considerations on interferon treatment in Behçet's disease.
Demiroglu H. Demiroglu H. Br J Ophthalmol. 2004 Feb;88(2):312. Br J Ophthalmol. 2004. PMID: 14736807 Free PMC article. No abstract available.
Behçet's syndrome: disease manifestations, management, and advances in treatment.
Yazici H, Fresko I, Yurdakul S. Yazici H, et al. Nat Clin Pract Rheumatol. 2007 Mar;3(3):148-55. doi: 10.1038/ncprheum0436. Nat Clin Pract Rheumatol. 2007. PMID: 17334337 Review.
Management of Behçet's syndrome.
Ozguler Y, Hatemi G. Ozguler Y, et al. Curr Opin Rheumatol. 2016 Jan;28(1):45-50. doi: 10.1097/BOR.0000000000000231. Curr Opin Rheumatol. 2016. PMID: 26555450 Review.

See all similar articles

Cited by

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
Kötter I, Zierhut M, Eckstein AK, Vonthein R, Ness T, Günaydin I, Grimbacher B, Blaschke S, Meyer-Riemann W, Peter HH, Stübiger N. Kötter I, et al. Br J Ophthalmol. 2003 Apr;87(4):423-31. doi: 10.1136/bjo.87.4.423. Br J Ophthalmol. 2003. PMID: 12642304 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information